BERN SIMO MUKAM: Open Payments
NPI 1841811205 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 8 payments from 4 companies in 2025. Trend: 2023 $97 · 2024 $186 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $122 |
| E.R. Squibb & Sons, L.L.C. | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Alkermes, Inc. | 1 | $21 |
Products named: ABILIFY MAINTENA, COBENFY, CAPLYTA, ARISTADA.
Industry payments across DC — which companies pay providers there.
